UBS Lux Equity Fund Biotech USD vs Barings Hong Kong China A

UBS Lux Equity Fund Biotech USD vs Barings Hong Kong China A

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    5

2. Barings Hong Kong China A

  • Security

    Barings Hong Kong China A USD Inc

  • Fee

    1.25%

  • ISIN

    IE0000829238

  • Holdings

    18

Fund Holdings

We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with Barings Hong Kong China A, we have 18 holdings where Tencent is the largest holding (9.55), followed by Alibaba (8.99) and China Construction Bank (5.24).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Barings Hong Kong China A.

UBS Lux Equity Fund Biotech USD Barings Hong Kong China A
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Tencent
China
9.55 %
2. Moderna Inc
9.21 %
2. Alibaba Group Holding Ltd ADR
China
8.99 %
3. Gilead Sciences Inc
USA
4.66 %
3. China Construction Bank Corp Class H
China
5.24 %
4. BioNTech SE
4.13 %
4. Meituan Class B
China
4.96 %
5. Karuna Therapeutics Inc
3.75 %
5. JD.com Inc
China
4.54 %
- 6. Xiaomi Corp Class B
China
4.3 %
- 7. Pinduoduo Inc
China
4.17 %
- 8. Ping An Insurance Co
China
3.47 %
- 9. NetEase ADR
China
3.15 %
- 10. China Merchants Bank Class H
China
2.65 %
- 11. Trip.com Group Ltd
Singapore
2.21 %
- 12. Agricultural Bank of China Ltd Class H
China
2.16 %
- 13. China Pacific Insurance Co Ltd Class H
China
2.1 %
- 14. BYD Co Ltd Class H
China
2.08 %
- 15. Li Auto Inc
China
1.55 %
- 16. BeOne Medicines Ltd
China
1.44 %
- 17. PetroChina Co Ltd Class H
China
1.32 %
- 18. China Shenhua Energy Co Ltd Class H
China
1.3 %

The list of fund holdings was last updated on September 10, 2025.